Stock Price
2.02
Daily Change
-0.03 -1.46%
Monthly
-17.21%
Yearly
-3.81%
Q1 Forecast
2.07

Mesoblast reported $2.3B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Avita Medical AUD 105.47M 35.32M Dec/2025
Clinuvel Pharmaceuticals AUD 520.28M 83.45M Jun/2025
Cochlear AUD 13.02B 4.03B Mar/2026
CSL USD 71.32B 15.44B Mar/2026
Pacific Edge NZD 194.21M 87.84M Dec/2025
Paradigm Biopharmaceuticals AUD 91.31M 27.46M Mar/2026
PYC Therapeutics AUD 7.72B 6.76B Mar/2026
Ramsay Health Care AUD 9.45B 1.52B Mar/2026
Starpharma Holdings AUD 179.24M 28.68M Mar/2026
Telix Pharmaceuticals AUD 5.07B 5.81B Dec/2025